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Background: Implementing infection control measures in light of healthcare-associated
infection (HAI) surveillance data can prevent HAIs. Surveillance has been associated with a
reduction of HAI in intensive care unit (ICU) patients, though the reasons for this
improvement remain unclear.
Aim: To evaluate changes in healthcare-associated infection (HAI) rates during three
surveys of the Italian Nosocomial Infections Surveillance in Intensive Care Units (ICUs)
network (SPIN-UTI) six-year project and to explore sources of variation of indicators of HAI
in the 65 participating ICUs.
Methods: The SPIN-UTI network adopted the European protocols for patient-based HAI
surveillance. Cumulative incidence, incidence density, infection rates adjusted for device-rtment GF Ingrassia,
, 95123 Catania, Italy.
).
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Surveillancedays, and device utilization ratios were calculated for each survey and compared. To
identify risk factors multiple logistic regression analyses were performed. Crude excess
mortality was computed as the difference between the crude overall case-fatality rate of
patients with and without HAI.
Findings: The risk of ICU-acquired infections increased in the third survey compared with
previous (relative risk: 1.215; 95% confidence interval: 1.059e1.394). Among risk factors,
the number of hospitalized patients requiring ICU admission and the Simplified Acute
Physiology Score II increased from 73.7% to 78.1% and from 37.9% to 40.8% respectively.
Althoughmortality rates remained unchanged, HAIs trebled the risk of death.Acinetobacter
baumannii was the most frequently reported micro-organism in the third survey (16.9%),
whereas in the previous surveys it ranked third (7.6%) and second (14.3%).
Conclusions: The study highlighted the increased risk of HAI, at least partially explained
by the greater severity and number of hospitalized patients requiring ICU admission.
Furthermore, the management of intubation procedures and of ventilated patients was
identified as a potential target for infection control interventions to decrease the growing
risk of HAI in ICUs.
ª 2013 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.Introduction
Reporting and analysing healthcare-associated infection
(HAI) surveillance data, with subsequent changes to infection
control measures, can prevent HAIs.1e4 Conducting surveil-
lance has been associated with a reduction of HAI rates in
intensive care unit (ICU) patients, although the particular
reasons for this decrease are still difficult to determine.5e7
The Italian Nosocomial Infections Surveillance in ICUs
network, Sorveglianza Prospettica delle Infezioni Nosocomiali
nelle Unita` di Terapia Intensiva (SPIN-UTI), was established in
Italy in 2005 by the Italian Study Group of Hospital Hygiene
(GISIO)of the ItalianSocietyofHygiene,PreventiveMedicineand
PublicHealth (SItI).8 TheSPIN-UTIprojecthasadoptedaprotocol
based on that from the Hospitals in Europe Link for Infection
Control through Surveillance (HELICS) network, subsequently
updated in accordance with the European Centre for Disease
Control and Prevention (ECDC) HAIICU protocol.9,10 Italy e first
among the European Countries to follow the HELICS-ICU
protocol e had conducted a validation study on the SPIN-UTI
surveillance data in order to determine the sensitivity, speci-
ficity, and positive and negative predictive values of HAI data.11
The SPIN-UTI network has been acknowledged by the Italian CCM
(Centro per il Controllo delle Malattie, Ministry of Health) and
has been included in the HELICS-ICU network and as a partner of
the IPSE (Improving Patient Safety in Europe) project, of the
BURDEN (Burden of Disease and Resistance in European Nations)
project, and of the IMPLEMENT (Implementing Strategic Bundles
for Infection Prevention and Management) project.
Here, we report surveillance data from the three surveys of
the SPIN-UTI six-year project (2006e2011), in order to evaluate
any change in infection rates during the study period and to
explore sources of variation of indicators of HAI in the 65
participating ICUs.Methods
Surveillance methodology
Each survey of the SPIN-UTI project consisted of six months
of patient-based surveillance conducted between the last
quarter of one year and the first quarter of the following year.The first and second surveys, respectively conducted from
November 2006 to April 2007, and from October 2008 to March
2009, adopted methods and definitions of the HELICS-ICU pro-
tocol.8,9 In the third survey, carried out from October 2010 to
March 2011, the protocol was updated following the ECDC
HAIICU protocol, implemented in 2010 by the ECDC’s TESSy, The
European Surveillance System for communicable diseases.10
Hospital participation was voluntary and results were
handled confidentially. Codes for hospitals and ICUs and pa-
tient identifiers were anonymous at the level of the surveil-
lance network. Surveillance was conducted by infection
control practitioners, intensive care specialists and other
personnel trained in the surveillance methodology and in ECDC
definitions. A web-based data collection procedure by means
of four electronic data forms, designed using SPSS Data Entry
Enterprise Server (SPSS Inc.), was used. At the end of each
survey, participating ICUs received a report on surveillance
data as feedback, in order to encourage infection control ac-
tivities on the basis of benchmark indicators.
The selected HAI indicators; cumulative incidence, incidence
density, infection rates adjusted for device-days and device uti-
lization ratios, were calculated for each survey as previously re-
ported and compared.8 The ‘relevant devices’ were: intubation,
central vascular catheters, and urinary catheters, respectively.
Crude excess mortality was computed as the difference be-
tween the crude overall case-fatality rate of patients with HAI
and the crude case-fatality rate of patients without HAI in the
ICU during the same survey period. Similarly, the crude excess
mortalities for patients who developed pneumonia, for patients
who developed a bloodstream infection (BSI) and for patients
with Acinetobacter baumannii infection were calculated.Statistical analyses
Statistical analyses were performed using the SPSS 14.0 statis-
tical package. Patients’ characteristics were compared using the
c2-test for categorical variables and Student’s t-test for contin-
uous variables; P  0.05 was considered significant. To compare
the infection rates and cumulative incidences between the three
surveys, relative risk (RR) values with 95% confidence intervals
(CIs) were determined. Device utilization ratios were compared
using the c2-test, and P 0.05 was considered significant.
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a caseecontrol study was designed for each edition of the
project. Case patients were those with HAI; control patients
were those without HAI. For quantitative variables the median
value was chosen as the cut-off point. The association of all
variables with the occurrence of HAI was assessed using the c2-
test. In order to take into account the influence of risk factors
for HAIs, for each survey of the project, significant variables
(P 0.05) were included in a multiple logistic regression model
for multivariate analysis, with stepwise variable selection.
Results
Surveillance indicators
A total of 65 ICUs participated in at least one edition of the
SPIN-UTI project continuously for at least six months, and
contributed data to the surveillance database. The number of
ICUs participating in each survey were: 49, 28 and 27, respec-
tively. A total of 14 ICUs (21.5%) participated in all three surveys.
Characteristics of the7694patients admitted to the ICUs formore
than two days during the three surveys are reported in Table I.
A significant increase in the mean age and Simplified Acute
Physiology Score (SAPS) II score of patients, a decrease in the
mean length of ICU stay and an increase in the proportion of pa-
tients admitted from the hospital rather than from community
were observed in the third survey of the project compared with
the previous surveys.
In all three surveys the most frequently detected infection
type was pneumonia. The risk of ICU-acquired infections,
estimated by computing the cumulative incidence and the
incidence density, significantly increased in the third survey
compared with the previous survey (Table II).
Time trends for HAI-associated micro-organisms
Relative frequencies of the most commonly isolated micro-
organisms in ICU-acquired infections are reported in Figure 1.Table I
Comparison of main characteristics of patients included in SPIN-UTI su
Characteristics SPIN-UTI
2006e2007 2008e2009
No. of ICUs (no. of hospitals) 49 (32) 28 (22)
No. of patients 3053 2163
Mean age (years) 63.7 66.0
Male (%) 61.6 62.8
Mean length of ICU stay (days) 11.6 10.5
Mortality (%) 17.7 18.3
SAPS II score (mean) 38.1 37.9
Origin of the patient from
hospital (%)
67.1 73.7
Trauma patients (%) 4.2 4.0
Patients needing acute
coronary care (%)
28.9 11.8
Impaired immunity (%) 3.7 3.8
Antibiotic treatment in 48 h
before or after ICU admission (%)
59.9 64.6
SPIN-UTI, Italian Nosocomial Infections Surveillance in ICUs network; ICA. baumannii was the most frequently reported micro-
organism in the third survey (16.9%), whereas in the two pre-
vious surveys it ranked third (7.6%) and second (14.3%),
respectively (P < 0.05). Pseudomonas aeruginosa was the most
frequently reported micro-organism in the first (19.4%) and in
the second surveys (16.9%) whereas in the third survey it
ranked second (14.4%) (P < 0.05). In the third survey a signifi-
cant increase in the frequency of isolation was reported for
Escherichia coli compared with previous surveys (10.6% versus
6.4% and 5.9%). In the last two surveys a significant increase in
the frequency of isolation was reported for Klebsiella pneu-
moniae (8.6% and 9.3% versus 5.3%). For Staphylococcus epi-
dermidis a significant decrease was observed in the second
survey compared with the first (3.8% versus 6.9%) and then a
significant increase in the third survey compared with the
second (6.4% versus 3.8%). Finally, for Staphylococcus aureus a
significant decrease in the frequency of isolation was reported
in the third and in the second surveys compared with the first
(5.4% and 5.5% versus 9.6%).
Relative frequencies and site-specific pathogen distribu-
tions of the most frequently isolated micro-organisms in ICU-
acquired infections are reported in Table III.
Risk trends estimated by computing the cumulative inci-
dence, the incidence density and the device-associated infec-
tion rates for A. baumannii and E. coli-associated infection did
not differ significantly from those computed for infections
associated with other micro-organisms (data not shown).Risk factor analysis
To take into account the influence of risk factors for HAIs,
multiple logistic regression analyses with stepwise variable
selection were performed for each survey of the project.
Among risk factors identified in each survey, and taking into
account the type of ICU and the Acute Physiology And Chronic
Health Evaluation (APACHE) II score, the proportion of patients
being admitted to ICUs from other hospital wards and the SAPSrveys
P-value, comparison between:
2010e2011 1st and 2nd
surveys
1st and 3rd
surveys
2nd and 3rd
surveys
27 (22) e e e
2478 e e e
67.1 0.00 0.00 0.01
59.7 0.41 0.14 0.03
10.0 0.00 0.00 0.18
18.2 0.61 0.61 0.98
40.8 0.82 0.00 0.00
78.1 0.00 0.00 0.00
3.9 0.78 0.61 0.83
13.9 0.00 0.00 0.00
3.5 0.87 0.65 0.56
62.8 0.00 0.00 0.21
U, Intensive Care Unit; SAPS, Simplified Acute Physiology Score.
Table II
Comparison of infection indicators in the three surveys of the SPIN-UTI project
Indicators SPIN-UTI RR (95% CI) or P-value, comparison between:
2006e2007 2008e2009 2010e2011 2nd and 1st
surveys
3rd and 1st
surveys
3rd and 2nd
surveys
Pneumonia (%) 53.6 47.3 51.7
Bloodstream infection (%) 23.4 22.5 25.7
Urinary tract infection (%) 16.7 22.3 15.6
Catheter-related infection (%) 6.3 7.9 7.1
Cumulative incidence of infections
(per 100 patients)
19.8 19.9 22.3 1.01 (0.89e1.14) 1.12 (1.00e1.26) 1.13 (0.99e1.28)
Cumulative incidence of infected
patients (per 100 patients)
11.7 11.9 14.2 1.02 (0.88e1.19) 1.2a (1.06e1.39) 1.19a (1.03e1.39)
Incidence density
(per 1000 patient-days)
17.1 19.0 22.4 1.11 (0.98e1.26) 1.31a (1.17e1.47) 1.18a (1.04e1.34)
Percentage of patients
who experienced
pneumonia
8.4% 7.5% 9.9%
Intubator-associated pneumonia
rate (per 1000 intubator-days)
15.6 12.9 17.3 0.83a (0.69e0.99) 1.11 (0.94e1.31) 1.34a (1.11e1.62)
Percentage of patients who
experienced a BSI
3.9% 3.5% 5.0%
BSIs rate (per 1000 patient-days) 4.0 4.3 5.7 1.08 (0.83e1.39) 1.43a (1.13e1.80) 1.33a (1.02e1.72)
UC-associated UTIs
(per 1000 UC-days)
4.2 4.5 3.7 1.07 (0.81e1.42) 0.88 (0.66e1.18) 0.82 (0.61e1.10)
CVC-associated infections rate
(per 1000 CVC-days)
1.6 1.7 1.8 1.06 (0.66e1.72) 1.13 (0.71e1.78) 1.06 (0.66e1.69)
Intubator utilization ratio 0.55 0.64 0.62 P < 0.00 P < 0.00 P < 0.00
CVC utilization ratio 0.58 0.82 0.85 P < 0.00 P < 0.00 P < 0.00
UC utilization ratio 0.58 0.82 0.90 P < 0.00 P < 0.00 P < 0.00
SPIN-UTI, Italian Nosocomial Infections Surveillance in ICUs network; RR, relative risk; CI, confidence interval; BSI, bloodstream infection; UTI,
urinary tract infection; CRI, catheter-related infection; UC, urinary catheter; CVC, central venous catheter.
Device-associated infection rates: number of device-related infections per 1000 device-days.
Utilization ratios: number of device days/number of patient-days.
a Statistically significant (P  0.05).
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78.1% and from 37.9 to 40.8 (mean values) respectively.
Mortality analysis
During the three surveys, mortality rates remained un-
changed (Table I), whereas the risk of death increased for
infected patients from RR¼ 2.25 (95% CI: 1.90e2.66) in the first
survey, to RR ¼ 2.96 (95% CI: 2.48e3.54) in the second survey,
and to RR ¼ 3.19 (95% CI: 2.71e3.74) in the third. The crude
excess mortality for patients with HAI increased from 19.3% in
the first survey to 29.2% in the second and 30.7% in the third.
The crude excess mortality for patients with pneumonia
increased from 19.1% in the first survey to 31.4% in the second
and to 32.3% in the third. The crude excess mortality for pa-
tients with BSI increased from 17.1% in the first survey to 32.9%
in the second and 27.2% in the third. Among the infected pa-
tients, the crude excess mortality for patients with
A. baumannii-associated infection ranged from 10.1% in the
first survey to 25.7% in the second and 7.9% in the third.
Discussion
Indicators of HAIs provided by surveillance activities require
comparison with adequate reference data to stimulate furtherinfection control activities. In fact, HAI indicators have been
used widely as benchmarks to enhance quality of care.12 SPIN-
UTI indicators computed for the first two surveys were similar
to those described in European reports.13e16 The most recent
European data reported that, of 70,648 patients staying more
than two days in an ICU, 7.1% acquired pneumonia and 4.7%
acquired a BSI.16
Surveillance of HAIs, in conjunction with appropriate
infection control activities, have been reported by the Study of
the Efficacy of Nosocomial Infection Control (SENIC) as an
efficacious tool to reduce HAIs.17 Other subsequent studies
have reported a reduction of the HAI rates in ICU patients.5e7
Furthermore, since those studies are not controlled interven-
tion surveys, potential bias associated with other factors, such
as patient characteristics, cannot be excluded.7 Thus, it re-
mains an open question whether the reduction in HAI rates is
also influenced by confounding factors such as changes in the
healthcare system, in diagnostic procedures and/or in the pa-
tient characteristics.3 However, one study reports that
following implementation of an infection control programme
including HAI surveillance, protocol updates in response to the
data obtained, and assessment of caregiver compliance with
infection control measures, there was a significant decline in
the rate of urinary tract infection (UTI) and central venous
catheter (CVC)-related bacteraemia but not of ventilator-
Staphylococcus aureus
Escherichia coli
Staphylococcus epidermidis
Enterococcus faecalis
Candida albicans
Klebsiella pneumoniae
Acinetobacter baumannii
Pseudomonas aeruginosa
0% 10%
Reported HAIs
20%
Figure 1. The most frequently reported micro-organisms in healthcare-associated infections (HAIs) (per 100 micro-organisms) according
to the Italian Nosocomial Infections Surveillance in Intensive Care Units (SPIN-UTI) network. Stippled bars: 2010e11 period; grey bars:
2008e9 period; black bars: 2006e7 period.
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programme initiation, together with the lack of effective
prevention measures, was suggested to explain in part those
results.18
Participation in the SPIN-UTI surveillance was voluntary, and
the number of participating hospitals and ICUs varied between
surveys. A possible explanation for the decreasing number of
participating ICUs observed in the last two surveys is the cost
and the heavy workload required for patient-based surveil-
lance activities. However, trends in infection rates computed
for the 14 ICUs contributing data to all three surveys did not
differ from those computed for all 65 ICUs included (data not
shown). In order to take into account such a potential source of
bias, we adjusted for patients’ characteristics not only on
admission, but also in terms of the length of stay in ICUs and
exposure to invasive devices. In the SPIN-UTI project, risk-
adjusted indicators of HAIs show that, despite urinary
catheter-associated UTI rates and CVC-related infection rates
remaining unchanged during the three surveys, both the
intubator-associated pneumonia rate and BSI rate significantly
increased in the third survey. The real reasons for the increase
are difficult to determine. However, device-associated infec-
tion rates and device utilization ratios should be examined
together, so that preventive measures may be appropriately
targeted.19 In the SPIN-UTI project, an increase in the
intubator-associated pneumonia rate was shown together witha decrease in the intubator utilization ratio. Therefore,
because intubation is a significant risk factor for pneumonia, it
is recommended to target efforts not only towards reducing the
use of the device or limiting the duration of usage, but
also towards the appropriate management of intubation
procedures.
Furthermore, since the patient-based component of the
European protocol has been adopted for the SPIN-UTI surveil-
lance, data on risk factors and risk-adjusted indicators were
used in order to investigate sources of variation. Importantly,
the HAI rate increase observed in the present study was shown
to be associated with disease severity and treatment intensity,
as high SAPS II score and patient origin from the hospital were
identified as independent risk factors, and they were shown to
increase significantly in the third survey.
Finally, the first and the second surveys of the SPIN-UTI proj-
ect adoptedmethods and definitions of the HELICS-ICU protocol,
whereas in the third survey, the protocol was updated following
theECDCHAIICUprotocol. Inparticular the SPIN-UTIprotocolwas
updated, removing some variables such as those related to CVC
risk factors and the Glasgow score. The list of micro-organisms
was updated. The format of device and antibiotic exposure
data, with a start date and an end date, introduced in the new
European protocol have already been included in the SPIN-UTI
protocol since its first edition. As such, none of the changes in
the protocol is likely to affect infection rates.
Table III
Relative frequency (%) by site of the most numerous isolated
micro-organisms in intensive care unit-acquired infection
Site/micro-organism SPIN-UTI
2006e
2007
2008e
2009
2010e
2011
Pneumonia
Pseudomonas aeruginosa 23.5% 21.8% 18.7%
Staphylococcus aureus 14.1% 8.0%
Acinetobacter baumannii 10.6% 19.1% 22.0%
Escherichia coli 10.1%
Bloodstream infection
Staphylococcus epidermidis 24.0% 12.4% 20.6%
Pseudomonas aeruginosa 11.1% 11.6%
Candida albicans 7.6%
Acinetobacter baumannii 11.6% 11.1%
Klebsiella pneumoniae 11.6% 9.4%
Urinary tract infection
Pseudomonas aeruginosa 20.7% 14.0% 12.5%
Candida albicans 18.9%
Escherichia coli 18.9% 13.1% 22.9%
Acinetobacter baumannii 12.5%
Klebsiella pneumoniae 13.1%
Catheter-related infection
Pseudomonas aeruginosa 11.9% 18.8%
Staphylococcus epidermidis 11.9% 10.0%
Staphylococcus haemolyticus 11.9%
Acinetobacter baumannii 9.5% 15.0% 12.5%
Klebsiella pneumoniae 9.5% 10.0% 12.5%
Staphylococcus: other spp. 12.5%
SPIN-UTI, Italian Nosocomial Infections Surveillance in Intensive
Care Units network.
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isolated in the Italian ICUs underlines the importance of some
pathogens common to all European countries, and the emergence
of specific pathogens such as A. baumannii in countries such as
Italy, Lithuania, Portugal, Slovakiaand Spain.8,13,16,20 Thepresent
study also showed the increasing impact of A. baumannii, ranking
the most frequently reported micro-organism in the third survey.
However, this feature cannot be considered an explanatory
factor as risk trends estimated by computing indicators for
A. baumannii-associated infections did not differ significantly
from those computed for other micro-organisms.
Amost important part of hospital epidemiology is to study the
impact of risk factors on clinical outcomes and ICU mortality.
Although in our study mortality rates remained unchanged, the
risk of death significantly increased among infected patients.
Overall estimates highlight that HAIs treble the risk of death,
with an increasing crude excess mortality for patients with
pneumonia during the three surveys, an increasing crude excess
mortality for patients with BSI in the first and second surveys,
and an additional effect of A. baumannii-associated infections
in the first and second surveys.
The answer of the international scientific community to the
growing challenge represented by the HAI risk in ICU patients
consists mainly of efforts to implement and fulfill multidisci-
plinary projects. In the European context, the IMPLEMENT
project was designed to spread and test knowledge on how to
implement strategic bundles for infection prevention andmanagement in a sample of European ICUs, in order to inves-
tigate the effectiveness of tailored strategies to implement
bundled evidence-based preventive interventions on a large
scale (http://www.eu-implement.info). In fact, identification
of the most successful implementation tools for bundled in-
terventions will provide important information for policy-
makers, managers, and healthcare workers on best practices
for tackling the HAI problem.21
In conclusion, our study highlighted the increased risk of HAI,
at least partially explained by the greater severity and number
of hospitalized patients requiring ICU admission. Our patient-
based cohort design allowed us to compute detailed estimates
of the outcomes of infections such as case fatality rate and the
emerging role of A. baumannii in the Italian ICUs. We identified
the management of intubation procedures and of ventilated
patients as a potential target for infection control interventions
and as such the need of implementation of strategic bundles in
order to decrease the growing risk of HAI in the ICUs.Acknowledgements
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